Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

4th Annual Digi-Tech Pharma & AI 2020

13 May 2020 08:30 - 14 May 2020 17:30, London, United Kingdom


Introduction
The 4th Annual Digi-Tech Pharma & AI conference brings with it even more interactive sessions, expert speakers, senior professionals and decision makers from leading pharma, bio-tech and healthcare industry. Meet the decision makers, benchmark and learn from real-life use cases to drive organizational change and to understand the new cutting-edge technologies and practical solutions. In this 4th edition as we explore the novel technologies and developments reforming pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial intelligence, informatics and data science which has redefined the development of new drugs, tackle diseases, improving healthcare and much more.

The enhancements in data management and data integration are providing improvements to both the speed and quality of drug discovery and many clinical trial processes. To be in the forefront, a necessity for partnership and collaboration with healthcare provider is a must for the pharmaceutical companies, and these partnerships will also lead to massive advances in R&D using artificial intelligence in genomics and precision medicine to develop a deep understanding of the root causes of diseases.

The combination of AI, big data and IoT technologies are creating new innovations, also other eminent technologies like cloud computing, augmented reality, virtual reality and blockchain are being used extensively in the Pharmaceutical industry’s digital transformation.
 
It gives us a great pleasure to welcoming you to this international pharmaceutical technology conference 4th Annual Digi-Tech Pharma & AI 2020.

Sessions & Discussions at a glance:
 

Reimagining Pharma by Integrating Science and Technology:
  • Digital Technology trends in Pharma and Bio-Tech industry
  • Adopting AI and Machine Learning to unlock the full potential of Pharma
  • How pharma can integrate into digital health environment
  • Collaborative Innovation: Finding the right partners to leverage new technologies in Pharma
  • Patient Centred Drug Discovery
 
Digital Discovery and Clinical Trials: 
  • Applying AI to the design of lead compounds for new drugs
  • Algorithms and Models for drug discovery
  • AI and ML for Target Identification & Validation in Drug Discovery
  • Advancing Drug Discovery through quantum computing
  • Genomics & Drug Discovery
  • Virtual and Hybrid Clinical Trials
  • R&D Use Cases  
 
Decoding the Value of Data Science, Big Data & Informatics:
  • Implementation and relevance of FAIR data principles in Pharma R&D
  • Harnessing Data Science for Drug Combination Discovery
  • AI and Big Data: A powerful combination for future growth
  • The use of AI to make sense of clinical data
  • Use of big data for precision medicine
  • Multi-omics & clinical data to unlock the power of complex datasets
  • Integration and Visualization of translational Medicine Data
  • Data & Healthcare Analytics
  • Use Cases
Real-World Data & Real-World Evidence: 
  • The Growing Importance of Real-World Data
  • RWD for clinical research and drug development
  • RWE and RWD to support regulatory decision making
  • Real‐World Data Science to advance Patient Care
  • Managing real world data governance
  • Use Cases
 
Digital Health & Future Innovations:
  • Healthcare & Medical Technology
  • Adoption of IoT in Pharma
  • Potential of Cloud Computing in Pharma
  • Impact of Digital Health in Pharma
  • Digital Health strategy and Patient centric Clinical Trials
  • The convergence of Digital Therapeutics and Pharma in Digital Health
  • How pharma-health collaboration works on innovating drug discovery & patient experience
  • Blockchain and AI-based Platform

WHO SHOULD ATTEND THE CONFERENCE:

This event is designed for senior level attendees from various companies including pharmaceutical, biotechnological, biopharmaceutical, CRO’s, Diagnostics, solution provider and government institutions.
Attendees includes Chief Data Officer, VPs, GMs, Directors, Heads and Managers of
•             Drug Delivery Innovation
•             R&D IT
•             Big Data Solutions
•             AI/ Machine Learning
•             Cognitive Computing
•             Digital innovative strategic planning
•             Genomics & Drug Discovery
•             Virtual and Hybrid Clinical Trials
•             Real-World Data
•             Real-World Evidence
•             Data Management & Analytics
•             Data Sciences
•             Clinical trials and data management
•             Translational informatics
•             Data storage and analysis
•             Enterprise Architecture
•             Information Systems
•             Contract outsourcing service providers
•             Digital Health
•             Healthcare IT
•             Computational  Biology
•             Multi-channel Management
•             Blockchain and AI-based Platform
Speakers
  • BERNARD HAMELIN VP Head of Evidence Generation Sanofi, France
  • CHUANG KEE ONG Principal Bioinformatics Scientist, Assoc Direct AstraZeneca, United Kingdom
  • CATALINA CERNICA Head of Innovation UK LEO Innovation Lab, United Kingdom
  • ADRIAN CASSIDY VP & Global Head - Real World Evidence Novartis, Switzerland
  • ANGELA DOUGLAS Deputy Chief Scientific Officer NHS England, United Kingdom
  • BIRGE BERNS Senior Director, Actelion regulatory integration lead J&J, United Kingdom
  • LAWRENCE P PETALIDIS Chief Innovation and Business Officer Health Navigator, United Kingdom
  • JOAO INCIO Associate Medical Director, Global Strategy Vertex, United Kingdom
  • TIM CAVE CEO & Founder SaySo Medical , United Kingdom
  • IOANNIS PANDIS Senior Manager - Business Technology Leader J&J, United Kingdom
  • ABHINANDAN RAGHAVAN Principal Scientist and Technology Lead Novartis, Switzerland
  • JOHN MULCAHY CEO, HealthGenuity (Former Senior Director Merck), Poland
  • NATALIE PANKOVA Healthcare Lead Government Blockchain Association London, United Kingdom
  • Mark Milton-Edwards Head of Product & Health Sol - Digital Health Teva, United Kingdom

Venue
Holiday Inn London - Kensington High St.

Holiday Inn London - Kensington High St. , Wrights Ln, Kensington, London W8 5SP, United Kingdom, London, W85SP, United Kingdom

Committee
Organised by
Our conferences give an unique opportunity for knowledge exchange and discussions in a very professional setting. Experience a peer-to-peer connection and knowledge sharing through our exclusive networking opportunities that leads to innovation and collaboration. Our programme sessions are meticulously researched to give our delegates an excellent quality agenda and we strive to place our attendees at the center of everything we do for the conference.
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*